Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,554 | -60,827 | -38,893 | -22,341 | -18,700 |
| Depreciation Amortization | 531 | -239 | -107 | 187 | 329 |
| Income taxes - deferred | -479 | -1,310 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -427 | -2,846 | 2,050 | 726 | -576 |
| Other Working Capital | -8,830 | 2,741 | 4,999 | 216 | 463 |
| Other Operating Activity | 9,265 | 17,497 | 2,095 | 1,989 | 3,336 |
| Operating Cash Flow | $-37,494 | $-44,984 | $-29,857 | $-19,223 | $-15,148 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,776 | -57,768 | -59,732 | -35,095 | -16,048 |
| PPE Investments | N/A | -10 | -263 | -25 | -12 |
| Net Acquisitions | N/A | 610 | N/A | N/A | N/A |
| Sale Of Investment | 34,800 | 75,645 | 36,659 | 24,922 | 15,835 |
| Investing Cash Flow | $29,024 | $18,477 | $-23,336 | $-10,198 | $-225 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 14,450 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -1,396 | N/A | N/A |
| Common Stock Issued | 41,902 | 9,249 | 81,923 | 37,595 | 12,739 |
| Other Financing Activity | 0 | -123 | 0 | -166 | 0 |
| Financing Cash Flow | $41,902 | $23,576 | $80,527 | $37,429 | $12,739 |
| Beginning Cash Position | 44,426 | 47,358 | 20,023 | 12,015 | 14,649 |
| End Cash Position | 77,858 | 44,426 | 47,358 | 20,023 | 12,015 |
| Net Cash Flow | $33,433 | $-2,932 | $27,334 | $8,008 | $-2,634 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,494 | -44,984 | -29,857 | -19,223 | -15,148 |
| Capital Expenditure | N/A | -10 | -263 | -25 | -12 |
| Free Cash Flow | -37,494 | -44,994 | -30,120 | -19,248 | -15,159 |